Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alkermes Plc (NQ: ALKS)
19.77 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 4:59 PM EST, Feb 24, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 17.80 (3)
Ask (Size) 20.05 (2)
Prev. Close 19.77
Today's Range 19.77 - 19.77
52wk Range 16.65 - 37.75
Shares Outstanding 145,827,889
Dividend Yield N/A
Performance
YTD
+0.05%
+0.05%
1 Month
+15.28%
+15.28%
3 Month
-7.66%
-7.66%
6 Month
+0.92%
+0.92%
1 Year
-42.29%
-42.29%
Top News
More News
Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 40th Annual Health Care Conference
Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020 at 3:30... Read More
from PR Newswire
Alkermes to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26, 2020 at 9:00 a.m. ET (2:00 p.m.... Read More
from PR Newswire
More News
Read More
Alkermes Plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2019 and Provides Financial Expectations for 2020
from PR Newswire
Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results
from PR Newswire
Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder
from PR Newswire
Alkermes' Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan Healthcare Conference
from PR Newswire
Analysts Predict 19% Upside For FBT
category ETFs
from ETF Channel
Alkermes Targets Bipolar Disorder And Schizophrenia
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
Alkermes PLC (ALKS) Q4 2019 Earnings Call Transcript
category Market News , ALKS
from Motley Fool
7.3% Return Seen to Date on SmarTrend Alkermes Plc Call (ALKS)
from Comtex SmarTrend® News Briefs
Analysts See 12% Upside For FTXH
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.